High-producer allele of tumour necrosis factor-alpha is part of the susceptibility MHC haplotype in severe Puumala virus-induced nephropathia epidemica

Scandinavian Journal of Infectious Diseases

Volumn 30, Issue 5, 1998, Pages 532-534

  Kanerva, Mari ^a   Vaheri, Antti ^a   Mustonen, Jukka ^b   Partanen, Jukka ^c  

^a UNIVERSITY OF HELSINKI   (Finland)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ALLELE; ARTICLE; CONTROLLED STUDY; GENETIC POLYMORPHISM; HAPLOTYPE; HOSPITALIZATION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; PHENOTYPE; PROMOTER REGION; PUUMALA VIRUS; RISK FACTOR;

ALLELES; GENETIC PREDISPOSITION TO DISEASE; HANTAVIRUS; HANTAVIRUS INFECTIONS; HAPLOTYPES; HLA ANTIGENS; HUMANS; MAJOR HISTOCOMPATIBILITY COMPLEX; PHENOTYPE; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RISK FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032423206     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365549850161629     Document Type: Article

References (20)

1. Mustonen J, Brummer-Korvenkontio M, Hedman K, Pasternack A, Pietilä K, Vaheri A. Nephropathia epidemica in Finland: a retrospective study of 126 cases. Scand J Infect Dis 1994; 26: 7-13.
2. Cosgriff TM, Lewis RM. Mechanisms of disease in hemorrhagic fever with renal syndrome. Kidney Int 1991; 40 (Suppl 35): S72-9.
3. Cotran RS, Pober JS. Cytokine-endothelial interactions in inflammation, immunity, and vascular injury. J Am Soc Nephrol 1990; 1: 225-35.
4. Yang CW, Bang BK. Changes of tumor necrosis factor-α in patients with hemorrhagic fever with renal syndrome. J Catholic Med College 1992; 45: 819-30.
5. Linderholm M, Ahlm C, Settergren B, Waage A, Tärnvik A. Elevated plasma levels of tumor necrosis factor (TNF)-alpha, soluble TNF receptors, interleukin (IL)-6, and IL-10 in patients with hemorrhagic fever with renal syndrome. J Infect Dis 1996; 173: 38-43.
6. Wilson AG, Symons JA, McDowell TL, McDevit HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor ápromoter on transcriptional activation. Proc Natl Acad Sci USA 1997; 94: 3195-9.
7. Brinkman BN, Zuijdgesst D, Kaijzel EL, Breedveld FC, Verweij CL. Relevance of the tumor necrosis factor alpha (TNF-alpha) -308 promoter polymorphisms in TNF-alpha gene regulation. J Inflamm 1996; 46: 32-41.
8. Stuber F, Udalova IA, Book M, Drutskaya LN, Kuprash DV, Turetskaya RL, Schade FU, Nedospasov SA. 308 tumor necrosis factor (TNF) polymorphism is not associated with survival in severe sepsis and is unrelated to lipopolysaccharide inducibility of the human TNF promoter. J Inflamm 1996; 46: 42-50.
9. Wilson AG, di Giovine FS, Blakemore AIF, Duff GW. Single base polymorphism in the human tumor necrosis factor alpha (TNFα) gene detectable by NcoI restriction of PCR product. Hum Molec Genet 1992; 1: 353.
10. Bouma G, Crusius JBA, Oudkerk Pool M, Kolkman JJ, von Blomberg BME, Kostense PJ, Gipghart MJ, Schreuder GMTh, Meuwissen SGM, Peña AS. Secretion of tumour necrosis factor a and lymphotoxin α in relation to polymorphisms in the TNF genes and HLA-DR alleles. Relevance for inflammatory bowel disease. Scand J Immunol 1996; 43: 456-63.
11. McGuire W, Hill AVS, Allsopp CEM, Greenwood BM, Kwjatkowski D. Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria. Nature 1994; 371: 508-11.
12. Nadel S, Newport MJ, Booy R, Levin M. Variation in the tumor necrosis factor-α gene promoter region may be associated with death from meningococcal disease. J Infect Dis 1996; 174: 878-80.
13. Cabrera M, Shaw MA, Sharpes C, Williams H, Castes M, Convit J, Blackwell JM. Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis. J Exp Med 1995; 182: 1259-64.
14. Roy S, McGuire W, Mascic-Taylor CGN, Saha B, Hazra SK, Hill AVS, Kwiatkowski D. Tumor necrosis factor promoter polymorphism and susceptibility to lepromatous leprosy. J Infect Dis 1997; 176: 530-2.
15. Mustonen J, Partanen J, Kanerva M, Pietilä K, Vapalahti O, Pasternack A, Vaheri A. Genetic susceptibility to severe course of nephropathia epidemica caused by Puumala hantavirus. Kidney Int 1996; 49: 217-21.
16. Dawkins RL, Martin E, Andreas-Zietz A, Keller E, Partanen J, Arnaiz-Villena A, Vicario JL, Alper C. Linkage disequilibrium, interlocus association and ancestral haplotypes. In: du Pont B, ed. Immunobiology of HLA. New York: Springer, 1989: 891-2.
17. Wilson AG, de Vries N, Pociot F, di Giovine FS, van der Putte LBA, Duff GW. An allelic polymorphism within the human tumor necrosis factor α promoter region is strongly associated with HLA Al, B8 and DR3 alleles. J Exp Med 1993; 177: 557-60.
18. Svejgaard A, Ryder LP. HLA and disease associations: detecting the strongest association. Tissue Antigens 1994; 43: 18-27.
19. Rudwaleit M, Tikly M, Khamashta M, Gibson K, Klinke J, Hughes G, Wordsworth P. Interethnic differences in the association of tumor necrosis factor promoter polymorphisms with systemic lupus erythematosus. J Rheumatol 1996; 23: 1725-8.
20. McManus R, Wilson AG, Mansfield J, Weir DG, Duff GW, Kelleher D. TNF2, a polymorphism of the tumour necrosis-α gene promoter, is a component of the celiac disease major histocompatibility complex haplotype. Eur J Immunol 1996; 26: 2113-8.